PFTs before and after pirfenidone therapy in stable and progressive group.

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/PFTs_before_and_after_pirfenidone_therapy_in_stable_and_progressive_group_/11772885 数据链接链接失效反馈

官方服务：

资源简介：

PFTs before and after pirfenidone therapy in stable and progressive group.

创建时间：

2020-01-30

Table4_Investigation of the Pharmacological Effect and Mechanism of Jinbei Oral Liquid in the Treatment of Idiopathic Pulmonary Fibrosis Using Network Pharmacology and Experimental Validation.DOCX

中药网络药理学

特发性肺纤维化治疗

Overview: Idiopathic pulmonary fibrosis (IPF) is a disease caused by many factors, eventually resulting in lung function failure. Jinbei oral liquid (JBOL) is a traditional Chinese clinical medicine u

NIAID Data Ecosystem30

Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis

特发性肺纤维化治疗

胶原免疫耐受

Rationale Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scarring and matrix deposition. Recent reports highlight an autoimmune component in IPF

NIAID Data Ecosystem20

Table_1_Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis.DOCX

特发性肺纤维化治疗

肺泡动力学评估

Idiopathic pulmonary fibrosis (IPF) is a progressively and ultimately fatal lung disease. Previously it has been shown that intratracheal administration of alveolar epithelial type II cells (AE2C) in

NIAID Data Ecosystem10

A low DNA methylation epigenotype in squamous cell lung cancer and its association with idiopathic pulmonary fibrosis and poorer prognosis

鳞状细胞癌表观遗传学

特发性肺纤维化治疗

Comprehensive DNA methylation analysis in clinical samples of lung squamous cell carcinoma with or without tidiopathic pulmonary fibrosis. Infinium HumanMethylation450 BeadChip was used to obtain DNA

NIAID Data Ecosystem30

Supplementary Material for: Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis

特发性肺纤维化治疗

药物同情用药评估

Background: Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis (IPF) and has been shown to slow disease progression by reducing annual lung function decline. Objective: To evalu

NIAID Data Ecosystem20

PFTs before and after pirfenidone therapy in stable and progressive group.

资源简介：

相关数据集